Trial intelligence / Profile preview

Liquid vs Tablet Levothyroxine in Enteral Feeding

NCT04878614Phase 4Terminated

Sponsor
University of California, Los Angeles
Start
May 2021
Primary completion
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levothyroxine sodium in hypothyroidism, sponsored by University of California, Los Angeles. Started May 2021; status: terminated.

02

Drugs

levothyroxine sodium
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on NCT04878614.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04878614.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call